CHRM2 and cognitive disorder: Earlier evidence suggested that M2 muscarinic receptor antagonism may enhance memory due to their autoreceptor function, sparking interest as a potential treatment for cognitive disorders related to cholinergic dysfunction, such as AD (Rowe et al. 2003).